This Metric Says You Are Smart to Sell Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Co. (NYSE:BMY) was in 33 hedge funds' portfolio at the end of the first quarter of 2013.
Abbvie Inc. (ABBV)
Market is closed
News
- First
- << Previous
- 511 - 516
Coinstar, Inc. (CSTR), AbbVie Inc (ABBV) & More Stocks Billionaire Ken Fisher Loves
For the past 15 years, investment guru Ken Fisher's stock picks have outperformed the overall market by more than 5% on average each year.
Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into animal health products...
AbbVie Inc (ABBV), PepsiCo, Inc. (PEP) & More: 5 Stocks with 40 or More Years of Dividend Increases
Market-beating strategies are inherently hard to find.
Biogen Idec Inc. (BIIB): What Goes up Must Come Down
Biogen Idec Inc. (NASDAQ:BIIB) is one of those rare companies in the healthcare sector whose stock has relentlessly outperformed the broader market continuously for as long as one can remember.
AstraZeneca plc (ADR) (AZN): Hedge Funds are Bearish...What to Do?
Is AstraZeneca plc (ADR) (NYSE:AZN) worth your attention right now? The smart money is becoming less confident. The number of long hedge fund bets fell by 2 lately.
- First
- << Previous
- 511 - 516
Billionaire Hedge Funds
